To gain a deeper insight into the impact of CAVPENET-induced AKT inhibition on the metabolic pathways of PCa cells, the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were monitored over a span of 100 min, measured every 8.5 min. The gene discussed is AKT1; the disease is posterior cortical atrophy.